The Quality Problem

The research peptide market operates in a regulatory gray area. Vendors sell lyophilized peptide powders labeled "for research use only" — a designation that places them outside FDA oversight for human therapeutics. This means no required potency verification, no mandatory sterility testing, no standardized manufacturing processes, and no chain-of-custody guarantees.

The result is a market with enormous quality variance. Independent testing has revealed products marketed as 99% pure that tested below 65% purity, bacterial endotoxin contamination in supposedly sterile preparations, incorrect amino acid sequences (the wrong peptide entirely), and degradation products indicating improper storage or handling.

For anyone engaging with research peptides, the ability to evaluate vendor quality is not optional — it's the single most important factor in risk management.

Certificate of Analysis: What to Look For

A Certificate of Analysis (CoA) is the baseline quality document. Every reputable vendor should provide one for each batch. A meaningful CoA should include the specific peptide identity (sequence confirmation via mass spectrometry), purity percentage determined by HPLC (High-Performance Liquid Chromatography), the actual HPLC chromatogram (not just a number), the batch number and date of analysis, and the name and contact information of the testing laboratory.

Red flag: A CoA that lists only a purity percentage without the actual HPLC chromatogram is essentially a claim without evidence. The chromatogram is the proof. Without it, the document has limited value.

Third-Party vs. In-House Testing

The distinction between third-party and in-house testing is critical. In-house testing means the vendor tested their own product — an obvious conflict of interest. Third-party testing means an independent laboratory (ideally ISO-accredited) performed the analysis with no financial relationship to the vendor.

Best practice: the CoA should name a recognizable third-party analytical laboratory. The buyer should be able to verify the lab exists and offers peptide analysis services. Some vendors provide CoAs from labs that cannot be independently verified — another red flag.

Purity Thresholds

For research peptides, purity is typically reported as a percentage by HPLC. The general quality tiers are above 98%: pharmaceutical-grade research quality, which is what you want for any serious application; 95-98%: acceptable for many research purposes but may contain meaningful impurity fractions; below 95%: significant impurity content, unsuitable for applications requiring consistent dosing or biological activity; and below 90%: unacceptable. The impurity fraction may contain truncated peptide sequences, synthesis byproducts, residual solvents, or degradation products.

Endotoxin and Sterility Testing

For any peptide intended for reconstitution and injection in a research context, endotoxin testing (LAL or rFC assay) and sterility testing are additional quality layers. Endotoxins are bacterial cell wall fragments that can cause fever, inflammation, and in severe cases, septic shock. A peptide can be 99% pure by HPLC and still contain dangerous levels of endotoxins. Sterility testing confirms the absence of viable microorganisms. This is particularly important for lyophilized powders that will be reconstituted with bacteriostatic water.

Vendor Evaluation Framework

When evaluating a research peptide vendor, consider whether they provide third-party CoAs with HPLC chromatograms for every batch, whether endotoxin testing results are available (for injectable-format peptides), whether they identify their synthesis facility and analytical laboratory by name, whether they have a transparent return/replacement policy for quality issues, how long they've been operating (longevity suggests some level of reliability), whether their prices are realistic (unusually cheap peptides often reflect quality shortcuts), and whether they provide proper storage and handling instructions.

Storage and Handling

Even a perfectly synthesized peptide degrades if improperly stored. Lyophilized (freeze-dried) peptides should be stored at -20°C for long-term storage. Reconstituted peptides should be stored at 2-8°C and used within 7 to 14 days (peptide-dependent). Avoid repeated freeze-thaw cycles. Reconstitute with sterile water for injection (SWFI) or bacteriostatic water (BAC water). Use sterile technique during reconstitution.

Research Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice, a treatment recommendation, or an endorsement of any compound for human use. Peptides discussed here are investigational and not FDA-approved for the indications described. Always consult a licensed healthcare provider before using any peptide or supplement. "Research peptides" sold online are typically labeled "for research use only" and are not manufactured under pharmaceutical-grade conditions unless otherwise verified.